Patents by Inventor Matthew Shive

Matthew Shive has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20260069532
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: November 13, 2025
    Publication date: March 12, 2026
    Applicant: MEDINCELL S.A.
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
    Patent number: 12558309
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Grant
    Filed: September 15, 2023
    Date of Patent: February 24, 2026
    Assignee: MEDINCELL S.A.
    Inventors: Georges Gaudriault, Sylvestre Grizot, Mark Hurtig, Matthew Shive
  • Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
    Patent number: 11865205
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: January 9, 2024
    Assignee: MEDINCELL S.A.
    Inventors: Georges Gaudriault, Sylvestre Grizot, Mark Hurtig, Matthew Shive
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20240000703
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 4, 2024
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20210322302
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: January 25, 2021
    Publication date: October 21, 2021
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20200155449
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 21, 2020
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • Filler composition for soft tissue augmentation and reconstructive surgery
    Publication number: 20040047892
    Abstract: The present invention relates to a filler composition for soft-tissue augmentation and reconstructive surgery comprising an effective amount of an injectable thermo-gelling solution comprising 0.1 to 5.0% by weight of chitosan or collagen or a derivative thereof; and 1.0 to 20% by weight of a salt of polyol or sugar selected from the group consisting of mono-phosphate dibasic salt, mono-sulfate salt and a mono-carboxylic acid salt of polyol or sugar. The solution is stable and turns into a gel within a tem-perature range from 20 to 70° C. The gel has a cosmetically acceptable consistency for providing a mechanical support to surrounding soft tissues once injected therein. The composition can thus be used as filler for soft tissue augmentation and reconstructive surgery.
    Type: Application
    Filed: October 23, 2003
    Publication date: March 11, 2004
    Inventors: Eric Andre Desrosiers, Abdellatif Chenite, Cyril Chaput, Matthew Shive